GLYCOLIPIDS BRAIN TUMORS
GLYCOLIPIDS BRAIN TUMORS
批准号:
2272549
负责人:
THOMAS N SEYFRIED
金额:
$14.18万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-02-01 至 1998-01-31
中文摘要
描述:(改编自申请人摘要)总体目标
英文摘要
DESCRIPTION: (adapted from Applicant's Abstract) The broad objective
of this research is to characterize the composition of
glycosphingolipids (gangliosides and neutral glycolipids) in macrophages
that infiltrate experimental mouse brain tumors. Although
glycosphingolipids (GSLs) were studied previously in peritoneal
macrophages, there have been no previous studies in either man or mouse
on the GSL composition of macrophages that infiltrate brain tumors. Our
preliminary studies in mouse brain tumors suggest that host infiltrating
macrophages contribute significantly to the total GSL composition of
solid brain tumors growing in vivo. The proposed research will be
conducted on two experimental mouse brain tumors, ependymoblastoma and
CT-2A. The two tumors differ in growth behavior, ganglioside
composition and in the number of infiltrating macrophages. Glass bead
columns will be used to separate macrophages from tumor cells and non-
macrophage host-infiltrating cells after enzymatic tumor dissociation.
The proposed research will involve the following specific aims: 1) A
comparative analysis of GSLs in infiltrating macrophages isolated from
the two brain tumors growing in both the brain and subcutaneously in the
flank of the C57BL/6 mouse; 2) A similar analysis in these tumors
growing in the flank of the SCID (severe combined immune deficiency)
mouse. This second aim will determine the influence of host genetic
background on the GSLs of tumor-infiltrating macrophages. The
qualitative and quantitative analysis of the GSLs will involve high
performance thin-layer chromatography and gas-liquid chromatography,
respectively. TLC immunostaining will be used to quanitate the
macrophage enriched GSLs, asialo-GM1 (GA1) and GM1b. Although GSLs have
been considered for the classification, diagnosis and therapy of brain
tumors, it has not been established whether the GSLs are expressed in
the neoplastic tumor cells or in tumor-infiltrating host cells. The
proposed research can provide new insight on the cellular origin of
brain tumor-associated GSLs and on the role of environmental factors in
regulating the GSL composition of tumor-infiltrating macrophages.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Glycosphingolipid Effects on Brain Tumor Angiogenesis
-
批准号:6891290
-
项目类别:
-
资助金额:$24.33万
-
财政年份:2004
-
负责人:THOMAS N SEYFRIED
-
依托单位:
Glycosphingolipid Effects on Brain Tumor Angiogenesis
-
批准号:6777814
-
项目类别:
-
资助金额:$25.33万
-
财政年份:2004
-
负责人:THOMAS N SEYFRIED
-
依托单位:
Glycosphingolipid Effects on Brain Tumor Angiogenesis
-
批准号:7061813
-
项目类别:
-
资助金额:$23.76万
-
财政年份:2004
-
负责人:THOMAS N SEYFRIED
-
依托单位:
GLYCOSPHINGOLIPIDS IN MURINE NEURODEGENERATIVE DISEASES
-
批准号:6226974
-
项目类别:
-
资助金额:$23.47万
-
财政年份:2001
-
负责人:THOMAS N SEYFRIED
-
依托单位:
GLYCOSPHINGOLIPIDS IN MURINE NEURODEGENERATIVE DISEASES
-
批准号:6685220
-
项目类别:
-
资助金额:$20.59万
-
财政年份:2001
-
负责人:THOMAS N SEYFRIED
-
依托单位:
Glycosphingolipids in murine neurodegenerative diseases
-
批准号:7362400
-
项目类别:
-
资助金额:$39.99万
-
财政年份:2001
-
负责人:THOMAS N SEYFRIED
-
依托单位:
Glycosphingolipids in murine neurodegenerative diseases
-
批准号:7144285
-
项目类别:
-
资助金额:$25.89万
-
财政年份:2001
-
负责人:THOMAS N SEYFRIED
-
依托单位:
GLYCOSPHINGOLIPIDS IN MURINE NEURODEGENERATIVE DISEASES
-
批准号:6625234
-
项目类别:
-
资助金额:$20.59万
-
财政年份:2001
-
负责人:THOMAS N SEYFRIED
-
依托单位:
Glycosphingolipids in Murine Neurodegenerative Diseases
-
批准号:8550181
-
项目类别:
-
资助金额:$34.65万
-
财政年份:2001
-
负责人:THOMAS N SEYFRIED
-
依托单位:
GLYCOSPHINGOLIPIDS IN MURINE NEURODEGENERATIVE DISEASES
-
批准号:6476748
-
项目类别:
-
资助金额:$20.59万
-
财政年份:2001
-
负责人:THOMAS N SEYFRIED
-
依托单位:
Glycosphingolipids in murine neurodegenerative diseases
-
批准号:7564054
-
项目类别:
-
资助金额:$39.99万
-
财政年份:2001
-
负责人:THOMAS N SEYFRIED
-
依托单位:
Glycosphingolipids in murine neurodegenerative diseases
-
批准号:7280773
-
项目类别:
-
资助金额:$39.9万
-
财政年份:2001
-
负责人:THOMAS N SEYFRIED
-
依托单位:
GLYCOLIPIDS IN BRAIN TUMORS
-
批准号:6254172
-
项目类别:
-
资助金额:$1.96万
-
财政年份:1997
-
负责人:THOMAS N SEYFRIED
-
依托单位:
GLYCOLIPIDS BRAIN TUMORS
-
批准号:2272550
-
项目类别:
-
资助金额:$13.36万
-
财政年份:1995
-
负责人:THOMAS N SEYFRIED
-
依托单位:
GLYCOLIPIDS BRAIN TUMORS
-
批准号:2333009
-
项目类别:
-
资助金额:$13.88万
-
财政年份:1995
-
负责人:THOMAS N SEYFRIED
-
依托单位:
GANGLIOSIDE STUDIES
-
批准号:3409757
-
项目类别:
-
资助金额:$1.77万
-
财政年份:1987
-
负责人:THOMAS N SEYFRIED
-
依托单位:
GANGLIOSIDE STUDIES IN EMBRYOS
-
批准号:3409752
-
项目类别:
-
资助金额:$8.87万
-
财政年份:1987
-
负责人:THOMAS N SEYFRIED
-
依托单位:
GANGLIOSIDE STUDIES
-
批准号:3409759
-
项目类别:
-
资助金额:$11.62万
-
财政年份:1987
-
负责人:THOMAS N SEYFRIED
-
依托单位:
GANGLIOSIDE STUDIES
-
批准号:3409754
-
项目类别:
-
资助金额:$7.23万
-
财政年份:1987
-
负责人:THOMAS N SEYFRIED
-
依托单位:
GANGLIOSIDE STUDIES IN EMBRYOS
-
批准号:3409758
-
项目类别:
-
资助金额:$6.95万
-
财政年份:1987
-
负责人:THOMAS N SEYFRIED
-
依托单位:
国内基金
海外基金
基于DNA甲基化交互网络的癌症hallmark挖掘及其在癌症转移biomarker筛选中的应用
-
批准号:61602201
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2016
-
负责人:周雄辉
-
依托单位:
血清miRNAs成为一种新的biomarker在PD诊断中的价值和LRRK2基因调控的机制研究
-
批准号:81170309
-
项目类别:面上项目
-
资助金额:50.0万元
-
批准年份:2011
-
负责人:颜桥
-
依托单位:
非小细胞肺癌Biomarker的Imaging MS研究新方法
-
批准号:30672394
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2006
-
负责人:陆豪杰
-
依托单位: